Close Menu
Home » Oncgnostics Garners €1M to Support Clinical Trials of Epigenetic Cervical Cancer Test

Oncgnostics Garners €1M to Support Clinical Trials of Epigenetic Cervical Cancer Test

Oct 03, 2016
|
Madeleine Johnson
Premium

NEW YORK (GenomeWeb) – German start-up Oncgnostics recently raised €1 million ($1.1 million) to support clinical trials of an epigenetic assay called GynTect test for assessing cervical cancer risk.

The Jena-based firm raised €500,000 of the money via a crowdfunding mechanism called Seedmatch, with VC group and current investor, Beteiligungsmanagement Thüringen (BM-T) providing matching funds.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Snakes and Bats and People

An initial analysis suggests the novel coronavirus from Wuhan that is sickening people might come from snakes, a team of virologists writes at the Conversation.

Coyote Match in Chicago

DNA testing confirms captured Chicago coyote same as the one that bit a boy near a nature museum, the Chicago Tribune reports.

Viruses on Ice

An analysis of Tibetan ice cores uncovers more than two dozen previously unknown virus groups, LiveScience reports.

Nature Papers Examine Ancient Human DNA From Africa, Present Approach to Study Microbiota

In Nature this week: genomic analysis of four children buried in Cameroon approximately 3,000 and 8,000 years ago, and more.

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Feb
25
Featured Webinar

Long-Read Sequencing of Human Transcription Provides Insights into Metastatic Cancer

Sponsored by
Loop Genomics

This webinar will discuss a study that used long-read transcriptome sequencing to explore the distribution of isoforms in colon cancer samples and their metastasis counterparts. 

Feb
26
Featured Webinar

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

Sponsored by
Autogen

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.

What's Popular?

In PCR

  1. Biocartis, AstraZeneca Expand Lung Cancer Biomarker Study With Master Collaboration Agreement

  2. FNIH Team Selects Cancer Biomarkers in Phase I of Liquid Biopsy Reference Standards Project

    Premium

  3. Diagnostics Developers Leap Into Action on Novel Coronavirus Tests

    Premium

  4. OraSure's DNA Genotek Gets FDA Clearance for Sample Collection Kits

  5. Ontera Developing Single-Pore Sensor for Sepsis, TB, and Zika Diagnostic Testing

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.